×

Sustained release delivery of a thrombin inhibitor

  • US 20040213850A1
  • Filed: 04/22/2004
  • Published: 10/28/2004
  • Est. Priority Date: 04/25/2003
  • Status: Abandoned Application
First Claim
Patent Images

1. An oral pharmaceutical composition comprising a) a tablet core comprising a therapeutically effective amount of 3-fluoro-2-pyridylmethyl-3-(2,2-difluoro-2-(2-pyridyl)ethylamino)-6-chloropyrazin-2-one-1-acetamide, or a pharmaceutically acceptable salt thereof, a water swellable polymer, and a neutralizing agent, and b) a water insoluble film coating surrounding the tablet core, wherein the water insoluble film coated tablet core has a plurality of apertures.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×